InspireMD (NSPR) Capital Expenditures Growth (1y) (2011 - 2025)
InspireMD (NSPR) Capital Expenditures Growth (1y) (2011 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | -17.56% |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 34.96% |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | -6.72% |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | -5.35% |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 15.89% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -47.73% |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | -11.95% |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | -43.42% |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 27.22% |
| 10 | InspireMD | 45.74 Mn | -8.48 Mn | 1.18 Mn | 27.97% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 27.97% |
| Sep 30, 2025 | -21.85% |
| Jun 30, 2025 | 21.26% |
| Mar 31, 2025 | 84.10% |
| Dec 31, 2024 | 44.65% |
| Sep 30, 2024 | 338.54% |
| Jun 30, 2024 | 955.56% |
| Mar 31, 2024 | 680.00% |
| Dec 31, 2023 | 126.32% |
| Sep 30, 2023 | -57.52% |
| Jun 30, 2023 | -60.87% |
| Mar 31, 2023 | -32.43% |
| Dec 31, 2022 | -11.21% |
| Sep 30, 2022 | 43.95% |
| Jun 30, 2022 | 112.96% |
| Mar 31, 2022 | 42.31% |
| Dec 31, 2021 | 72.58% |
| Dec 31, 2020 | 16.98% |
| Dec 31, 2019 | 43.24% |
| Sep 30, 2019 | 3,200.00% |